Cargando…

OR18-05 Interleukin 21 Drives The Development Of Autoimmune Diabetes Mellitus During Immune Checkpoint Inhibitor Cancer Therapy

Disclosure: J.G. Ortega: None. L.N. Scott: None. S. Wang: None. S. Zhang: None. H. Chen: None. N. Huang: None. M. Lechner: None. Autoimmune diabetes mellitus is a rare but life-threatening side effect of immune checkpoint inhibitor (ICI) cancer therapy. Checkpoint inhibitors increase immune activati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Garcia Ortega, Jessica Rachel, Scott, Lauren N, Wang, Sarah, Zhang, Shile, Chen, Ho-Chung, Huang, Nicole, Lechner, Melissa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Diabetes And Glucose Metabolism
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10556985/ http://dx.doi.org/10.1210/jendso/bvad114.897

Ejemplares similares

THU299 Safety Of Immune Checkpoint Inhibitor Cancer Therapy In Patients With Pre-existing Type 1 Diabetes Mellitus: A Multi-Center Cohort Study
por: Hilder, Robin, et al.
Publicado: (2023)

Checkpoint Inhibitor-Associated Autoimmune Diabetes Mellitus: A Case Report
por: Gnanapragasam, Helen Prathiba, et al.
Publicado: (2021)

RF05 | PSUN376 Incidence of Diabetes Mellitus Following Pancreatic Surgery in Individuals with Multiple Endocrine Neoplasia Type 1
por: Else, Tobias, et al.
Publicado: (2022)

THU363 Misdiagnosing Latent Autoimmune Diabetes Mellitus In Adults: A Case Report
por: Rafat, Ummara, et al.
Publicado: (2023)

THU369 A Rare Case Of IgG4-related Autoimmune Pancreatitis And Diabetes Mellitus
por: Zahid, Maleeha, et al.
Publicado: (2023)

A Case of Immune Checkpoint Inhibitor Induced Autoimmune Diabetes
por: Thambuluru, Sirisha Reddy
Publicado: (2021)

LBSAT236 A Case of Immune Checkpoint Inhibitor Pembrolizumab Induced Simultaneous Rare Endocrinopathies, Type 1 DM (presenting As DKA) And Grave's Thyrotoxicosis, With Evidence Of Autoimmunity Development.
por: Arora, Gunjan, et al.
Publicado: (2022)

OR34-05 Second Phase Insulin Secretion Varies By Time Of Day And Body Mass Index
por: Naaman, Sandra, et al.
Publicado: (2023)

OR12-05 Blunting Of Sympathetic Activation Of Pancreas As A Cause For Hypoglycemic Unawareness In Hypoglycemia Associated Autonomic Failure
por: Thakkar, Keya, et al.
Publicado: (2023)

New Onset Autoimmune Diabetes Mellitus, Autoimmune Thyroiditis and Subsequent Autoimmune Hepatitis With Monoclonal Antibody to Programmed Cell Death-1 (PD-1) Protein Therapy in a Patient With Non Small Cell Lung Cancer: 18 Months Follow up Experience
por: Mandal, Kaushik, et al.
Publicado: (2021)

SUN-170 Development of Type 1 Diabetes Mellitus on Immune Checkpoint Inhibitor
por: Tsuei, Jessica, et al.
Publicado: (2019)

ODP260 New Type of Autoimmune Diabetes
por: Kumar, Surina, et al.
Publicado: (2022)

OR05-3 Mir-21 Contributes to Cytokine-Induced Beta Cell Dysfunction via Inhibition of mRNAs Regulating Beta Cell Identity
por: Ibrahim, Sara, et al.
Publicado: (2019)

SAT-673 Acute Onset Type 1 Diabetes Mellitus Caused by the Checkpoint Inhibitor Nivolumab
por: Ansari, Mohammad Jamal Uddin, et al.
Publicado: (2020)

THU353 Late Onset Of Immune Checkpoint Inhibitor-Related Diabetes After 3 Years
por: Avula, Sreekant, et al.
Publicado: (2023)

ODP213 Insulin Autoimmune Syndrome a rare case report
por: Paladugu, Sridevi
Publicado: (2022)

ODP220 Latent Autoimmune Diabetes of Adults and PCOS - an Unusual Combination
por: Pisklakova, Alexandra, et al.
Publicado: (2022)

PSUN275 Autoimmune Dysglycemia Syndrome (ADS) Associated with Multiple Rheumatological Conditions
por: Paz-Ibarra, Jose, et al.
Publicado: (2022)

SAT173 Insulin Autoimmune Syndrome: A Rare Diagnosis With Unique Features
por: Naqvi, Syeda, et al.
Publicado: (2023)

SAT-667 Partial Beta-Cell Destruction: An Atypical Case of Immune Checkpoint Inhibitor Diabetes Mellitus
por: Quandt, Zoe, et al.
Publicado: (2020)

SAT-668 Liver Function Test in Type 1 Diabetes Mellitus and Prevalence of Other Autoimmune Disease in Type 1 Diabetes Mellitus
por: Anusha, Nadig, et al.
Publicado: (2020)

PSUN186 Comparison of Thyroid Function Test Screening in Patients with Diabetes Mellitus Type 2 versus Patients with Diabetes Mellitus Type 1
por: Aasim, Alina, et al.
Publicado: (2022)

PSUN250 Empagliflozin Induced Bladder Cancer in an Adult Patient With Latent Autoimmune Diabetes
por: Alzenaidi, Ahlam, et al.
Publicado: (2022)

SAT154 Insulin Autoimmune Syndrome In The Setting Of Metastatic Colon Cancer: Case Report
por: Bernal, Maria, et al.
Publicado: (2023)

OR18-06 Metabolomic And Genetic Architecture Of Gestational Diabetes Subtypes
por: Lee, Kristen, et al.
Publicado: (2023)

MON-LB121 New Onset Insulin Dependent Diabetes Mellitus Secondary to Treatment With Immune Checkpoint Inhibitor
por: Bitat, Syed Rabha
Publicado: (2020)

FRI665 Hirata's Syndrome: Autoimmune Hypoglycemia Diagnostic Pathway, A Mexican Case Report
por: De La Cruz, German Gonzalez, et al.
Publicado: (2023)

ODP214 INSULIN REQUIRING DIABETES MELLITUS(IRDM) and CAD
por: Singh, Santosh
Publicado: (2022)

THU318 Endocrine Phenotype Drives Mortality Risk At Presentation During Index Hospitalization With SARS-CoV-2 Infection: Differential Trait Signatures May Shed Some Light
por: Baez, Karla, et al.
Publicado: (2023)

ODP649 COVID-19 Induced Diabetic Ketoacidosis Which Unmasked Latent Autoimmune Diabetes In Adult
por: Alqaisi, Sura, et al.
Publicado: (2022)

PSUN263 Diagnosis of Latent Autoimmune Diabetes of Adulthood Unveiled After Initiation of an SGLT2 Inhibitor
por: Patel, Goonja, et al.
Publicado: (2022)

PSUN303 Nationwide Geospatial Analysis of Hospitalization in Diabetes Mellitus Complications
por: Lee, Claire, et al.
Publicado: (2022)

PSUN238 COVID 19 induced Type 1 Diabetes Mellitus
por: Ahsun, Sana, et al.
Publicado: (2022)

LBODP054 Hypogonadism in Diabetes Mellitus: Insulin Resistance, The Connecting Link?
por: Singh, Jaspreet, et al.
Publicado: (2022)

OR18-04 Leptin Decreases Gluconeogenesis And Gluconeogenic Substrate Availability In Patients With Lipodystrophy
por: Quaye, Emmanuel, et al.
Publicado: (2023)

OR18-01 Massively Parallel Functional Assay Of Extracellular Insulin Receptor Variants
por: Aslanzadeh, Vahid, et al.
Publicado: (2023)

THU358 A Case Of Latent Autoimmune Diabetes In Adults (LADA) Managed By Lifestyle And Dietary Intervention Alone
por: Waseem Ahmad, Malik, et al.
Publicado: (2023)

THU378 Presentation Of Autoimmune Destruction Of Pancreatic Beta Cells By Pembrolizumab In The Setting Of Existing Type 2 Diabetes
por: Seidenberg, Jacob, et al.
Publicado: (2023)

PSUN260 Diabetic Myconecrosis: a Rare Complication of Uncontrolled Diabetes Mellitus
por: Joseph, Marina, et al.
Publicado: (2022)

LBODP053 Significance Of Insulin Resistance And Development Of Type 2 Diabetes Mellitus
por: Rusalenka, Mariya, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_9la6q89qop59qpu5s66dg9d03c